- Supported exchanges /
- LSE /
- 0RQE.LSE
Idorsia Ltd. (0RQE LSE) stock market data APIs
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases. Its products include PIVLAZ (clazosentan), available in 150 mg, is indicated for the prevention of cerebral vasospasm, vasospasm-related cerebral infarction, and cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage securing; and QUVIVIQ (daridorexant) for the treatment of adult patients with insomnia. The company has a collaboration agreement with Janssen Biotech Inc. to jointly develop and commercialize aprocitentan and its derivative compounds or products; license agreement with Mochida Pharmaceutical for the supply, co-development, and comarketing of daridorexant; and Hoffman-La Roche Inc. to develop and commercialize PIVLAZ. It also has a collaboration with Neurocrine Biosciences, Inc. to develop and commercialize ACT-709478, which is in Phase II clinical trial for the treatment of epilepsy. The company was incorporated in 2017 and is headquartered in Allschwil, Switzerland.
Idorsia Ltd. Financial Data Overview
1.7165 | |
1.7505 | |
- | |
1.7577 | |
1.7165 | |
1.294-4.27 | |
1 498 M | |
131 M | |
128 M | |
-0.5459 | |
1.178 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Idorsia Ltd. Fundamental Data is available in our Financial Data APIs
- Net Revenue 128 M
- EBITDA -338 747 008
- Earnings Per Share -4.258
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Idorsia Ltd. Earnings via APIs
- Latest Release 2024-07-25
- EPS/Forecast NaN
Get Idorsia Ltd. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: